SIGA Announces New Drug Application Filing with FDA for Intravenous Formulation of TPOXX
May 04, 2021 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, May 04, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it has...
SIGA Technologies to Host Business Update Call on May 6th, 2021 Following Release of First Quarter 2021 Financial Results
April 29, 2021 08:00 ET
|
SIGA Technologies Inc.
NEW YORK, April 29, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
Cipla Therapeutics and SIGA Technologies Announce Strategic Partnership to support innovation and provide access to novel antibacterial drugs against biothreats
March 23, 2021 08:00 ET
|
SIGA Technologies Inc.
NEW YORK, March 23, 2021 (GLOBE NEWSWIRE) -- Cipla Therapeutics, a division of Cipla USA Inc., an affiliate of Cipla Limited (BSE: 500087; NSE: CIPLA EQ; referred to as "Cipla") and SIGA...
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2020
March 04, 2021 16:05 ET
|
SIGA Technologies Inc.
- Approximately 363,000 Courses of Oral TPOXX® Delivered to U.S. Government in 2020 – - International Contracts for the Purchase of up to Approximately $47 Million of Oral TPOXX® Since April 2020 – ...
SIGA Technologies to Host Business Update Call on March 4, 2021 Following Release of Year End 2020 Financial Results
February 26, 2021 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, Feb. 26, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that...
SIGA Announces Public Health Agency of Canada Contract Award to Purchase Up To Approximately $33 Million of Oral TPOXX®
January 13, 2021 16:45 ET
|
SIGA Technologies Inc.
Second Contract by a Canadian Governmental Agency for the Procurement of Oral TPOXX NEW YORK, Jan. 13, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage...
SIGA Technologies Chief Scientific Officer to Participate at NCT Asia Virtual Conference on November 13, 2020
November 12, 2020 16:05 ET
|
SIGA Technologies Inc.
NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr....
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2020
November 05, 2020 16:05 ET
|
SIGA Technologies Inc.
- Third Quarter includes Delivery of Approximately 134,000 Courses of TPOXX® to U.S. Government – - In October, the Public Health Agency of Canada Announced its Intent to Purchase up to 33,300...
SIGA Technologies to Host Business Update Call on November 5, 2020 Following Release of Third Quarter Financial Results
October 29, 2020 07:30 ET
|
SIGA Technologies Inc.
NEW YORK, Oct. 29, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that...
SIGA Announces Public Health Agency of Canada Intent to Purchase Up To 33,300 Courses of Oral TPOXX®
October 08, 2020 07:30 ET
|
SIGA Technologies Inc.
Public Health Agency of Canada Contract would be Second Contract by a Canadian Governmental Agency for the Procurement of Oral TPOXXDelivery of 18,500 Courses by March 31, 2023; Delivery of Additional...